Thrombin-Induced Calpain Activation Promotes Protease-Activated Receptor 1 Internalization

Area of Science:

• Cellular Biology
• Molecular Biology
• Ophthalmology

Background:

• Protease-Activated Receptors (PARs) are G-protein-coupled receptors activated by proteases like thrombin.
• PAR1 activation is implicated in fibroproliferative eye diseases, necessitating understanding of its inactivation mechanisms.
• PAR1 signaling involves increased intracellular calcium ([Ca+2]i) and phospholipase C (PLC) activation.

Purpose of the Study:

• To elucidate the mechanisms of Protease-Activated Receptor 1 (PAR1) inactivation following thrombin stimulation.
• To investigate the role of calcium signaling and calpain in PAR1 regulation.
• To identify novel pathways for terminating PAR1-mediated signaling in RPE cells.

Main Methods:

• Utilized the ARPE-19 human RPE cell line to study thrombin-induced signaling.
• Characterized calcium ([Ca+2]i) increases and calcium-dependent μ-calpain activation.
• Assessed α-spectrin degradation and PAR1 membrane expression changes.

Main Results:

• Thrombin stimulation of PAR1 in RPE cells leads to calcium influx and μ-calpain activation.
• Activated μ-calpain degrades α-spectrin, a protein essential for receptor endocytosis.
• This process results in decreased PAR1 expression on the cell membrane, indicating receptor inactivation.

Conclusions:

• Identified a novel μ-calpain-dependent mechanism for PAR1 inactivation.
• This pathway involves calcium-mediated calpain activation leading to PAR1 degradation and reduced membrane expression.
• Understanding this inactivation mechanism is critical for developing therapeutic strategies for PAR1-related eye diseases.